Chad Messer
Stock Analyst at Lake Street
(1.01)
# 3,823
Out of 5,063 analysts
29
Total ratings
34.48%
Success rate
-15.76%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chad Messer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSTX OS Therapies | Maintains: Buy | $18 → $17 | $1.71 | +894.15% | 2 | Nov 18, 2025 | |
| GNLX Genelux | Initiates: Buy | $16 | $4.96 | +222.91% | 1 | Oct 21, 2025 | |
| MNPR Monopar Therapeutics | Initiates: Buy | $106 | $92.80 | +14.22% | 1 | Sep 23, 2025 | |
| BOLT Bolt Biotherapeutics | Maintains: Buy | $4 → $75 | $4.70 | +1,495.74% | 2 | Aug 15, 2025 | |
| ONCY Oncolytics Biotech | Initiates: Buy | $7 | $1.01 | +596.52% | 1 | Aug 13, 2025 | |
| COYA Coya Therapeutics | Initiates: Buy | $16 | $5.98 | +167.56% | 1 | Jul 9, 2025 | |
| LTRN Lantern Pharma | Initiates: Buy | $25 | $3.08 | +713.01% | 1 | Apr 2, 2025 | |
| IMNM Immunome | Initiates: Buy | $23 | $18.53 | +24.12% | 1 | Apr 2, 2025 | |
| ESPR Esperion Therapeutics | Maintains: Strong Buy | $134 → $114 | $3.08 | +3,601.30% | 3 | Aug 3, 2021 | |
| CELC Celcuity | Initiates: Buy | $50 | $97.50 | -48.72% | 1 | Jul 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $48 | $65.44 | -26.65% | 2 | Jul 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $30 | $42.51 | -29.43% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $70.56 | -29.14% | 1 | Jun 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $29 | $9.68 | +199.59% | 2 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.80 | +457.10% | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $86 | $76.15 | +12.94% | 2 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $44 | $16.76 | +162.53% | 2 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $182 → $166 | $17.71 | +837.32% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $18 | $1.55 | +1,061.29% | 1 | May 5, 2020 |
OS Therapies
Nov 18, 2025
Maintains: Buy
Price Target: $18 → $17
Current: $1.71
Upside: +894.15%
Genelux
Oct 21, 2025
Initiates: Buy
Price Target: $16
Current: $4.96
Upside: +222.91%
Monopar Therapeutics
Sep 23, 2025
Initiates: Buy
Price Target: $106
Current: $92.80
Upside: +14.22%
Bolt Biotherapeutics
Aug 15, 2025
Maintains: Buy
Price Target: $4 → $75
Current: $4.70
Upside: +1,495.74%
Oncolytics Biotech
Aug 13, 2025
Initiates: Buy
Price Target: $7
Current: $1.01
Upside: +596.52%
Coya Therapeutics
Jul 9, 2025
Initiates: Buy
Price Target: $16
Current: $5.98
Upside: +167.56%
Lantern Pharma
Apr 2, 2025
Initiates: Buy
Price Target: $25
Current: $3.08
Upside: +713.01%
Immunome
Apr 2, 2025
Initiates: Buy
Price Target: $23
Current: $18.53
Upside: +24.12%
Esperion Therapeutics
Aug 3, 2021
Maintains: Strong Buy
Price Target: $134 → $114
Current: $3.08
Upside: +3,601.30%
Celcuity
Jul 27, 2021
Initiates: Buy
Price Target: $50
Current: $97.50
Upside: -48.72%
Jul 19, 2021
Maintains: Buy
Price Target: $33 → $48
Current: $65.44
Upside: -26.65%
Jun 28, 2021
Maintains: Buy
Price Target: $33 → $30
Current: $42.51
Upside: -29.43%
Jun 17, 2021
Initiates: Buy
Price Target: $50
Current: $70.56
Upside: -29.14%
May 14, 2021
Maintains: Buy
Price Target: $31 → $29
Current: $9.68
Upside: +199.59%
Apr 5, 2021
Initiates: Buy
Price Target: $10
Current: $1.80
Upside: +457.10%
Mar 23, 2021
Maintains: Buy
Price Target: $95 → $86
Current: $76.15
Upside: +12.94%
Jan 8, 2021
Maintains: Buy
Price Target: $35 → $44
Current: $16.76
Upside: +162.53%
Jan 8, 2021
Maintains: Buy
Price Target: $182 → $166
Current: $17.71
Upside: +837.32%
May 5, 2020
Maintains: Buy
Price Target: $15 → $18
Current: $1.55
Upside: +1,061.29%